PALO ALTO, CA
Allocation by class
Portfolio Concentration
Top 3 weight
23.9%
Top 10 weight
52.4%
Voting Authority Distribution
Total shares with voting rights: 101.77M
Full voting authority
101.77M
shares
Joint voting authority
0.00
shares
No voting authority
0.00
shares
Investment Discretion (by position count)
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Trevi Therapeutics IncSOLE | Common | 5.09M | SH | $95.02M 8.68% | 5.09M | 0.00 | 0.00 |
Praxis Precision MedicinesSOLE | Common | 271.12K | SH | $90.77M 8.29% | 271.12K | 0.00 | 0.00 |
Erasca IncSOLE | Common | 4.13M | SH | $75.61M 6.90% | 4.13M | 0.00 | 0.00 |
Arrivent BioPharma IncSOLE | Common | 1.68M | SH | $58.44M 5.34% | 1.68M | 0.00 | 0.00 |
Abivax SA - ADRSOLE | SPONSORED ADS | 414.90K | SH | $55.29M 5.05% | 414.90K | 0.00 | 0.00 |
Tango Therapeutics IncSOLE | Common | 1.38M | SH | $43.13M 3.94% | 1.38M | 0.00 | 0.00 |
Corvus Pharmaceuticals IncSOLE | Common | 2.81M | SH | $41.92M 3.83% | 2.81M | 0.00 | 0.00 |
Bright Minds Biosciences IncSOLE | Common | 557.17K | SH | $39.11M 3.57% | 557.17K | 0.00 | 0.00 |
Sinovac Biotech Ltd.SOLE | SHS | 5.90M | SH | $38.19M 3.49% | 5.90M | 0.00 | 0.00 |
Tenax Therapeutics IncSOLE | Common | 2.50M | SH | $36.38M 3.32% | 2.50M | 0.00 | 0.00 |
Aclaris Therapeutics, Inc.SOLE | Common | 6.69M | SH | $35.41M 3.23% | 6.69M | 0.00 | 0.00 |
Dyne Therapeutics IncSOLE | Common | 1.56M | SH | $34.59M 3.16% | 1.56M | 0.00 | 0.00 |
Dianthus Therapeutics IncSOLE | Common | 354K | SH | $34.51M 3.15% | 354K | 0.00 | 0.00 |
Alto Neuroscience IncSOLE | Common | 1.21M | SH | $31.90M 2.91% | 1.21M | 0.00 | 0.00 |
DBV Technologies SASOLE | SPONSORED ADS | 1.84M | SH | $30.25M 2.76% | 1.84M | 0.00 | 0.00 |
SAB Biotherapeutics IncSOLE | Common | 7.30M | SH | $28.47M 2.60% | 7.30M | 0.00 | 0.00 |
Moonlake ImmunotherapeuticsSOLE | Class A ORD | 1.40M | SH | $27.26M 2.49% | 1.40M | 0.00 | 0.00 |
LB Pharmaceuticals IncSOLE | Common | 800K | SH | $25.96M 2.37% | 800K | 0.00 | 0.00 |
Minerva Neurosciences IncSOLE | Common | 4.32M | SH | $23.99M 2.19% | 4.32M | 0.00 | 0.00 |
Design Therapeutics IncSOLE | Common | 1.61M | SH | $23.34M 2.13% | 1.61M | 0.00 | 0.00 |
Oric Pharmaceuticals IncSOLE | Common | 1.85M | SH | $20.02M 1.83% | 1.85M | 0.00 | 0.00 |
CAMP4 Therapeutics CorporationSOLE | Common | 4.25M | SH | $18.56M 1.69% | 4.25M | 0.00 | 0.00 |
Faeth Therapeutics IncSOLE | Common | 722.02K | SH | $18.05M 1.65% | 722.02K | 0.00 | 0.00 |
Achieve Life Sciences Inc.SOLE | Common | 2.75M | SH | $17.96M 1.64% | 2.75M | 0.00 | 0.00 |
Compass Therapeutics IncSOLE | Common | 7.76M | SH | $16.99M 1.55% | 7.76M | 0.00 | 0.00 |